Literature DB >> 30977878

A systematic review: characteristics, complications and treatment of spondylodiscitis.

L Gentile1, F Benazzo, F De Rosa, S Boriani, G Dallagiacoma, G Franceschetti, M Gaeta, F Cuzzocrea.   

Abstract

OBJECTIVE: This systematic review focuses on 5 key elements that may improve the decision-making process in spondylodiscitis: the infective agent, segmental instability, abscess development, neurological compromise and focus of infection.
MATERIALS AND METHODS: We included 64 studies published between May 2012 and May 2017, that reported both a description of the discitis and comparative data regarding the disease and its complications.
RESULTS: The majority of cases were caused by Staphylococcus spp (40.3%) and involved the lumbosacral region (52.3%). 27.8% of cases were associated to neurological compromise, 30.4% developed an abscess, 6.6% were associated to instability, and 54.7% underwent surgery. The abscesses mostly involved the lumbosacral region (60.4%) with paravertebral localization; 32.6% of cases involved the thoracic region, showing mostly epidural localization; a small number of cases (7%) involved the cervical region, mostly with epidural localization. 95% of paravertebral abscesses were treated percutaneously, while 85.7% of epidural cases underwent "open" surgery. Spinal cord compression mainly occurred in the cervical region (55.9%), neurological deficit was observed in over half of cases (65%), and surgery was required in most of the cases (83.9%). The majority of cases of instability involved the lumbosacral region (53.3%) and underwent surgery (87%). The focus of infection was mostly lumbosacral (61%) and almost all cases (95%) were treated surgically.
CONCLUSIONS: Spondylodiscitis is a complex and multifactorial disease, whose diagnosis and management are still challenging. Due to its potential morbidity, it is extremely important to investigate the 5 key elements discussed in this paper in order to provide an early diagnosis and initiate the most effective treatment.

Entities:  

Year:  2019        PMID: 30977878     DOI: 10.26355/eurrev_201904_17481

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  8 in total

1.  [Clinically relevant incidental finding].

Authors:  Hannes Neumann; Alexey Surov; Maciej Pech
Journal:  Radiologe       Date:  2021-02-15       Impact factor: 0.635

Review 2.  Differentiation between infectious spondylodiscitis versus inflammatory or degenerative spinal changes: How can magnetic resonance imaging help the clinician?

Authors:  Fausto Salaffi; Luca Ceccarelli; Marina Carotti; Marco Di Carlo; Gabriele Polonara; Giancarlo Facchini; Rita Golfieri; Andrea Giovagnoni
Journal:  Radiol Med       Date:  2021-04-02       Impact factor: 3.469

3.  Progressive Back Pain due to Aspergillus nidulans Vertebral Osteomyelitis in an Immunocompetent Patient: Surgical and Antifungal Management.

Authors:  Mark K Lyons; Matthew T Neal; Naresh P Patel; Holenarasipur R Vikram
Journal:  Case Rep Orthop       Date:  2019-07-02

4.  Obesity in spontaneous spondylodiscitis: a relevant risk factor for severe disease courses.

Authors:  Benjamin Schoof; Martin Stangenberg; Klaus Christian Mende; Darius Maximilian Thiesen; Dimitris Ntalos; Marc Dreimann
Journal:  Sci Rep       Date:  2020-12-14       Impact factor: 4.379

5.  Surgical management of spontaneous thoracic and lumbar spondylodiscitis by fixation and debridement.

Authors:  Ahmed Hosameldin; Mohammed Hussein; Ehab Abdelhalim; Mohammed Shehab; Ashraf Osman
Journal:  Surg Neurol Int       Date:  2022-02-11

6.  Is It Back Pain or Pott's Disease?

Authors:  Patrícia Carvalho; Cátia Fernandes; Serzelina Cunha; Cláudia Teixeira
Journal:  Cureus       Date:  2022-03-04

7.  A disease that is difficult to diagnose and treat: evaluation of 343 spondylodiscitis cases.

Authors:  Safak Kaya; Sehmuz Kaya; Seyhmus Kavak; Senol Comoglu
Journal:  J Int Med Res       Date:  2021-11       Impact factor: 1.671

8.  Influence of microbiological diagnosis on the clinical course of spondylodiscitis.

Authors:  Martin Stangenberg; Klaus Christian Mende; Malte Mohme; Theresa Krätzig; Lennart Viezens; Anna Both; Holger Rohde; Marc Dreimann
Journal:  Infection       Date:  2021-07-12       Impact factor: 3.553

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.